Skip to search formSkip to main contentSkip to account menu

zonisamide

Known as: Zonisamida, 1,2-benzisoxazole-3-methanesulfonamide, 3-sulfamoylmethyl-1,2-benzisoxazole 
A sulfonamide derivative with an anticonvulsant property. The exact mechanism of action remains to be elucidated. Zonisamide appears to block sodium… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
OBJECTIVE Zonisamide and bupropion have been investigated for weight reduction in obese adults. We conducted a preliminary study… 
2007
2007
The aim of the study was to assess the use of a novel anticonvulsant, zonisamide, in patients with treatment refractory anxiety… 
Review
2006
Review
2006
SummaryIn the last 12 years, 10 new anticonvulsants have been approved by the U.S. Food and Drug Administration and. as a result… 
Highly Cited
2004
Highly Cited
2004
The authors evaluated zonisamide for symptomatic infantile spasms in 23 patients. Spasm cessation, EEG evolution, and… 
Review
2002
Review
2002
Zonisamide is a novel anticonvulsant that is structurally and mechanistically unique, compared with other antiepilepsy drugs… 
1994
1994
Summary: Zonisamide (ZNS)‐induced behavior disorders are reported in a 1‐year‐old girl and a 3‐year‐old boy. Both patients, who… 
Highly Cited
1986
Highly Cited
1986
Zonisamide (CI-912) is an experimental antiepileptic drug. Since this drug is to be evaluated initially as an add-on medication…